P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE

• Biree Andemariam,
• Modupe Idowu,
• Nirmish Shah,
• Richard Drachtman,
• Archana Sharma,
• Alexander Glaros,
• Maureen Achebe,
• Alecia Nero,
• Brooke Hayward,
• Michelle Xu,
• Susanna Curtis

Affiliations

Biree Andemariam

1 New England Sickle Cell Institute, University of Connecticut Health, Farmington, United States

Modupe Idowu

2 University of Texas Health, McGovern Medical School, Houston, United States

Nirmish Shah

3 Duke University School of Medicine, Durham, United States

Richard Drachtman

4 Rutgers Medical School, New Brunswick, United States

Archana Sharma

4 Rutgers Medical School, New Brunswick, United States

Alexander Glaros

5 Central Michigan University, Division of Pediatric Hematology/Oncology, Detroit, United States

Maureen Achebe

6 Harvard Medical School, Brigham and Women’s Hospital, Detroit, United States

Alecia Nero

7 University of Texas Southwestern Medical Center, Dallas, United States

Brooke Hayward

8 Pfizer, Inc., New York, United States

Michelle Xu

8 Pfizer, Inc., New York, United States

Susanna Curtis

9 Albert Einstein College of Medicine, Bronx, United States